(S (NP-SBJ (NP Stable/JJ expression/NN) (PP of/IN (NP transdominant/JJ Rev/NN protein/NN)) (PP in/IN (NP human/JJ T/NN cells/NNS))) (VP inhibits/VBZ (NP human/JJ immunodeficiency/NN virus/NN replication/NN)) ./.)
(S (NP-SBJ The/DT (NP (NP human/JJ immunodeficiency/NN virus/NN) (PRN -LRB-/-LRB- (NP HIV/NN) -RRB-/-RRB-)) Rev/NN protein/NN) (VP is/VBZ (ADJP-PRD essential/JJ (PP-COOD (PP for/IN (NP (NP viral/JJ structural/JJ protein/NN expression/NN) (PRN -LRB-/-LRB- (NP-COOD (NP Gag/NN) ,/, (NP Pol/NN) ,/, and/CC (NP Env/NN)) -RRB-/-RRB-))) and/CC ,/, hence/RB ,/, (PP for/IN (NP viral/JJ replication/NN))))) ./.)
(S (PP In/IN (NP transient/JJ transfection/NN assays/NNS)) ,/, (NP-SBJ-17 (NP mutant/JJ forms/NNS) (PP of/IN (NP Rev/NN)) (SBAR *ICH*-100/-NONE-)) (VP have/VBP (VP been/VBN (VP identified/VBN (NP *-17/-NONE-) (SBAR-100 (WHNP-18 that/WDT) (S (NP-SBJ *T*-18/-NONE-) (VP-COOD (VP inhibit/VBP (NP wild-type/JJ Rev/NN activity/NN)) and/CC therefore/RB (VP suppress/VBP (NP viral/JJ replication/NN)))))))) ./.)
(S (S-ADV (NP-SBJ */-NONE-) (VP To/TO (VP determine/VB (SBAR whether/IN (S (NP-SBJ-19 such/JJ transdominant/JJ Rev/NN proteins/NNS) (VP could/MD (VP provide/VB (NP (NP long-term/JJ protection/NN) (PP against/IN (NP HIV/NN infection/NN))) (PP without/IN (S (NP-SBJ *-19/-NONE-) (VP affecting/VBG (NP T/NN cell/NN function/NN))))))))))) ,/, (NP-SBJ-20 T/NN leukemia/NN cell/NN lines/NNS) (VP were/VBD (ADVP stably/RB) (VP transduced/VBN (NP *-20/-NONE-) (PP with/IN (NP (NP a/DT retroviral/JJ vector/NN) (VP encoding/VBG (NP (NP (NP a/DT transdominant/JJ mutant/NN) (PP of/IN (NP the/DT Rev/NN protein/NN))) ,/, (NP M10/NN))))))) ./.)
(S (SBAR-ADV While/IN (S (NP-SBJ all/PDT the/DT M10-expressing/JJ cell/NN lines/NNS) (VP remained/VBD (ADJP-PRD infectable/JJ (PP by/IN (NP HIV-1/NN)))))) ,/, (NP-SBJ-21 these/DT same/JJ cells/NNS) (VP failed/VBD (S (NP-SBJ-22 *-21/-NONE-) (VP to/TO (VP support/VB (NP a/DT productive/JJ replication/NN cycle/NN) (SBAR-TMP (WHADVP-24 when/WRB) (S (NP-SBJ-23 *-22/-NONE-) (VP infected/VBN (NP *-23/-NONE-) (PP with/IN (NP (NP a/DT cloned/VBN isolate/NN) (PP of/IN (NP HIV-1/NN)))) (ADVP *T*-24/-NONE-)))))))) ./.)
(S (PP In/IN (NP addition/NN)) ,/, (NP-SBJ (QP two/CD out/IN of/IN three/CD) M10-expressing/JJ CEM/NN clones/NNS) (VP were/VBD (ADJP-PRD also/RB resistant/JJ (PP to/TO (NP (NP (ADJP highly/RB productive/JJ) infection/NN) (PP by/IN (NP a/DT heterogeneous/JJ HIV-1/NN pool/NN)))))) ./.)
(S (NP-SBJ (NP Expression/NN) (PP of/IN (NP M10/NN))) (VP did/VBD not/RB (VP affect/VB (NP (NP induction/NN) (PP of/IN (NP HIV/NN transcription/NN)) (VP mediated/VBN (NP */-NONE-) (PP by/IN (NP-LGS-COOD (NP the/DT kappa/NN B/NN regulatory/JJ element/NN) or/CC (NP Tat/NN))))))) ./.)
(S (ADVP Importantly/RB) ,/, (NP-SBJ (NP constitutive/JJ expression/NN) (PP of/IN (NP Rev/NN M10/NN))) (VP did/VBD not/RB (VP alter/VB (NP (NP the/DT secretion/NN) (PP of/IN (NP interleukin/NN 2/CD))) (PP in/IN response/NN to/TO (NP (NP mitogen/NN stimulation/NN) (PP of/IN (NP (NP-COOD (NP EL-4/NN) and/CC (NP Jurkat/NN)) cells/NNS)))))) ./.)
(S (NP-SBJ (NP The/DT inhibition/NN) (PP of/IN (NP HIV/NN infection/NN)) (PP in/IN (NP (NP cells/NNS) (VP (ADVP stably/RB) expressing/VBG (NP a/DT transdominant/JJ Rev/NN protein/NN)))) ,/, (PP in/IN the/DT absence/NN of/IN (NP (NP any/DT deleterious/JJ effect/NN) (PP on/IN (NP T/NN cell/NN function/NN)))) ,/,) (VP suggests/VBZ (SBAR that/IN (S (NP-SBJ such/PDT a/DT strategy/NN) (VP could/MD (VP provide/VB (NP a/DT therapeutic/JJ effect/NN) (PP in/IN (NP (NP the/DT T/NN lymphocytes/NNS) (PP of/IN (NP acquired/VBN immunodeficiency/NN syndrome/NN patients/NNS))))))))) ./.)
